Related Experiment Video
Updated: Nov 11, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
Published on: November 30, 2022
Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality
Ivan Cusacovich1, Álvaro Aparisi2, Miguel Marcos3
1Internal Medicine Department, Hospital Clínico Universitario de Valladolid, Spain.
Corticosteroid pulses significantly reduced 60-day mortality in severe COVID-19 patients. This treatment offers a potential survival benefit for critically ill individuals requiring hospitalization.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pharmacology
Background:
- Severe COVID-19 presents a significant mortality risk.
- Effective treatments for severe COVID-19 are crucial.
- Corticosteroids are used in inflammatory conditions, but their role in severe COVID-19 needs clarification.
Purpose of the Study:
- To evaluate the impact of corticosteroid pulses on 60-day mortality.
- To assess the efficacy of methylprednisolone treatment in hospitalized severe COVID-19 patients.
Main Methods:
- Multicenter retrospective cohort study.
- Propensity score matching (PSM) to control for confounding factors.
- Cox regression analysis to determine mortality risk.
Main Results:
- Patients receiving corticosteroid pulses showed a significantly lower 60-day mortality rate (30.3%) compared to the non-exposed group (42.9%).
- This survival benefit remained significant after PSM and Cox regression analysis (HR 0.561, p=0.039).
Conclusions:
- Corticosteroid pulses may significantly reduce mortality in severe COVID-19.
- The study's rigorous selection criteria provide a reliable basis for comparing outcomes.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Pericarditis III: Medical Management
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids